Crystallization (Comment) | Organism |
---|---|
in complex with inhibitors 5-[(3-nitrobenzyl)amino]benzene-1,3-dicarboxylic acid and 3,4-dihydroxy-5-((3-nitrobenzyl)oxy)benzoic acid | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3,4-dihydroxy-5-((3-nitrobenzyl)oxy)benzoic acid | most potent isophthalate inhibitor found | Mycobacterium tuberculosis | |
5-[(3-nitrobenzyl)amino]benzene-1,3-dicarboxylic acid | most potent gallate-based inhibitor found | Mycobacterium tuberculosis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WPX7 | - |
- |
Mycobacterium tuberculosis ATCC 25618 | P9WPX7 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
5-dehydroquinate | - |
Mycobacterium tuberculosis | dehydroshikimate + H2O | - |
? | |
5-dehydroquinate | - |
Mycobacterium tuberculosis ATCC 25618 | dehydroshikimate + H2O | - |
? |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0075 | - |
5-[(3-nitrobenzyl)amino]benzene-1,3-dicarboxylic acid | pH 7.0, 25°C | Mycobacterium tuberculosis | |
0.01 | - |
3,4-dihydroxy-5-((3-nitrobenzyl)oxy)benzoic acid | pH 7.0, 25°C | Mycobacterium tuberculosis |